We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+16.29%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.82B
AUM Growth
+$1.31B
(+20%)
Cap. Flow
+$158M
Cap. Flow
% of AUM
2.03%
Top 10 Holdings %
Top 10 Hldgs %
19.27%
Holding
869
New
65
Increased
350
Reduced
240
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$43.7M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$30.4M |
| 3 |
Gilead Sciences
GILD
|
+$28.3M |
| 4 |
Biogen
BIIB
|
+$26.7M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$25.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$75.2M |
| 2 |
LOXO
Loxo Oncology, Inc
LOXO
|
+$28.1M |
| 3 |
Danaher
DHR
|
+$27.9M |
| 4 |
Agilent Technologies
A
|
+$26.4M |
| 5 |
McCormick & Company Non-Voting
MKC
|
+$18M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.36% |
| 2 | Technology | 15.96% |
| 3 | Financials | 11.25% |
| 4 | Consumer Discretionary | 8.98% |
| 5 | Communication Services | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
iShares MSCI Emerging Markets ETF
EEM
$28.6B
| – | – |
-7,082
| Closed | -$277K |
|
777
Energizer
ENR
$1.44B
| – | – |
-9,000
| Closed | -$406K |
|
778
EQT Corp
EQT
$32.5B
| – | – |
-119,373
| Closed | -$2.25M |
|
|
EXK
779
Endeavour Silver
EXK
$2.35B
| – | – |
-50,000
| Closed | -$107K |
|
780
First American
FAF
$7.79B
| – | – |
-10,000
| Closed | -$446K |
|
781
Fortune Brands Innovations
FBIN
$6.14B
| – | – |
-10,195
| Closed | -$331K |
|
|
FL
782
DELISTED
Foot Locker
FL
| – | – |
-62,313
| Closed | -$3.31M |
|
783
Graco
GGG
$13B
| – | – |
-205,154
| Closed | -$8.59M |
|
784
Gildan
GIL
$9.38B
| – | – |
-17,083
| Closed | -$518K |
|
785
Goldgroup Mining Inc.
GORO
$162M
| – | – |
-10,000
| Closed | -$40K |
|
786
Harley-Davidson
HOG
$2.61B
| – | – |
-73,343
| Closed | -$2.5M |
|
787
ImmunityBio
IBRX
$7.32B
| – | – |
-232,400
| Closed | -$270K |
|
|
IFN
788
Aberdeen India Fund
IFN
$490M
| – | – |
-60,000
| Closed | -$1.21M |
|
789
iShares MSCI India ETF
INDA
$6.77B
| – | – |
-85,000
| Closed | -$2.83M |
|
790
Insmed
INSM
$22.7B
| – | – |
-70,567
| Closed | -$926K |
|
791
IPG Photonics
IPGP
$3.81B
| – | – |
-27,907
| Closed | -$3.16M |
|
792
Jefferies Financial Group
JEF
$13B
| – | – |
-381,897
| Closed | -$5.93M |
|
793
Lincoln Electric
LECO
$14.1B
| – | – |
-94,778
| Closed | -$7.47M |
|
794
Lexicon Pharmaceuticals
LXRX
$991M
| – | – |
-509,000
| Closed | -$3.38M |
|
795
Mattel
MAT
$4.3B
| – | – |
-45,661
| Closed | -$456K |
|
796
Medtronic
MDT
$108B
| – | – |
-13
| Closed | -$1K |
|
797
Maximus
MMS
$3.2B
| – | – |
-6,000
| Closed | -$391K |
|
798
OR Royalties Inc
OR
$5.54B
| – | – |
-103,632
| Closed | -$908K |
|
799
Plains GP Holdings
PAGP
$5.16B
| – | – |
-15,595
| Closed | -$313K |
|
800
PG&E
PCG
$47.2B
| – | – |
-231,396
| Closed | -$5.5M |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q1 2019 Portfolio in Review
As of Q1 2019, Candriam SCA held 869 positions worth $7.82B, up 20% from $6.51B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Candriam SCA's Q1 2019 filing shows 65 new, 350 increased, 240 reduced and 81 closed positions. Its largest new stake was Baozun: 640,000 shares worth $26.6M. The largest sale was Celgene Corp, an estimated $75.2M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 35% a quarter earlier, followed by Technology and Financials.
- Candriam SCA's largest Q1 2019 buy was Baozun: 640,000 shares worth $26.6M.
- Candriam SCA added most to Merck in Q1 2019, an estimated $43.7M increase.
- Candriam SCA's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $75.2M.
- Candriam SCA fully exited Loxo Oncology, Inc in Q1 2019, selling an estimated $28.1M.
- Candriam SCA's ten largest holdings make up 19% of its $7.82B portfolio in Q1 2019.
- Candriam SCA opened 65 new positions and closed 81 in Q1 2019.
- Candriam SCA's portfolio value rose 20% quarter-over-quarter to $7.82B.
Based on Candriam SCA's 13F filing for Q1 2019, filed 2 May 2019.